PTEN deficiency is a common defect in juvenile myelomonocytic leukemia
Authors:
- Robert P. CastleberryRCRobert P. Castleberry
- Peter D. EmanuelPEPeter D. Emanuel
- 1 May 2009
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 33 (5) , 671-677
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- PTEN function in normal and neoplastic growthCancer Letters, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Inherited predispositions and hyperactive Ras in myeloid leukemogenesisPediatric Blood & Cancer, 2005
- PTEN function: how normal cells control it and tumour cells lose itBiochemical Journal, 2004
- Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cellsCancer Cell, 2002
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathwayProceedings of the National Academy of Sciences, 1999
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cellsNature Genetics, 1996
- Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitorsBlood, 1991